Why the study?
Documentation of a decrease in fibrin content measured and illustrated on two-dimensional images had not been reported previously in an adult patient with purulent pericarditis.
Does intrapericardial administration of a fibrinolytic agent reduce fibrin content in an adult patient with purulent pericarditis?
Does intrapericardial administration of a fibrinolytic agent reduce fibrin content in an adult patient with purulent pericarditis?
This case report demonstrates the utility of two-dimensional transthoracic echocardiography in documenting the reduction of fibrin content following intrapericardial fibrinolytic therapy in purulent pericarditis.
Answers are grounded in this paper and cite their sources.
Echocardiography may document fibrin reduction after intrapericardial fibrinolysis in purulent pericarditis; leaves open need for controlled trials.
We describe an adult patient who presented with purulent pericarditis in whom two-dimensional transthoracic echocardiography demonstrated a marked decrease in the area of the right ventricular wall together with the overlying fibrin following intrapericardial administration of a fibrinolytic agent. Documentation of this decrease by measurements performed and illustrated on two-dimensional images have not been reported previously in an adult patient with purulent pericarditis, to the best of our knowledge.
No takes yet. Share an insight, caveat, or question.
Abdelsalam et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: